Advertisement
U.S. markets closed

Healixa Inc. (EMOR)

Other OTC - Other OTC Delayed Price. Currency in USD
0.1520+0.0260 (+20.63%)
At close: 03:56PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1260
Open0.1260
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1200 - 0.1520
52 Week Range0.1200 - 0.5000
Volume79,540
Avg. Volume36,404
Market Cap117.795M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for EMOR

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • HEALIXA INC
    Analyst Report: Baxter International Inc.Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter offers tools to help patients with acute and chronic kidney failure, which it plans to spin off by mid-2024. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.
    Rating
    Fair Value
    Economic Moat
    17 hours agoMorningstar
View more
  • GlobeNewswire

    Healixa Inc. Announces Regional Distribution Agreement for its Eternal Spring™ Deposition Water Harvester™ Technology

    Huntington, NY, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Healixa Inc. (OTC: EMOR) (“Healixa” or the “Company”) is proud to announce that the Company has entered into a Regional Distribution Agreement with Caribbean Resource Solutions LLC to enable sales and distribution for its Eternal Spring™ Deposition Water Harvester™ technology in 18 countries and territories within the Caribbean Basin. This Regional Distribution Agreement is anticipated to begin generating sales and distribution for the Company’s

  • GlobeNewswire

    Healixa and Modern Homestead Launch Eternal Spring™ Deposition Water Harvester™

    After 13 Years of R&D, a Revolutionary Solution to Global Water Insecurity ArrivesNew York, NY and Pleasant Shade, TN, Jan. 12, 2024 (GLOBE NEWSWIRE) -- In a groundbreaking advancement in sustainable water technology, Healixa Inc. (OTC: EMOR), in collaboration with Modern Homestead, has unveiled the Eternal Spring™ Deposition Water Harvester™. This cutting-edge device represents the culmination of 13 years of dedicated research and development, setting a new benchmark in the field of water gener

  • GlobeNewswire

    Healixa and Modern Homestead Unveil the "Eternal Spring™" Powered by Revolutionary Deposition Water Harvesting™ Technology

    New York, NY and Pleasant Shade, TN, Dec. 20, 2023 (GLOBE NEWSWIRE) -- After years of relentless research and development, Healixa, in partnership with Modern Homestead, proudly announces the commercial launch of the world's first "Eternal Spring™" powered by innovative Deposition Water Harvesting™ (DWH™) Technology. This groundbreaking device, the culmination of over a decade of dedication and innovation, is poised to address the global water crisis by extracting a staggering average of 500 lit